Comparing the current results to its competitors, Escalon Medical reported Revenue decrease in the 3 quarter 2026 year on year by -24.92 %, despite the revenue increase by the most of its competitors of 4.7 %, recorded in the same quarter.
Escalon Medical 's Comment on Competition and Industry Peers
The Company operates in the ophthalmic market both in the United States and internationally, facing competition from ophthalmic-focused companies that market prescription devices and pharmaceuticals exclusively for ophthalmic indications, as well as from integrated companies offering products for ophthalmic and other indications. The market is dominated by several large companies, with numerous smaller companies ranging from start-ups to established players. The Company primarily competes through technological innovation protected by intellectual property. Sonomed is identified as a competitor with over 30 years of presence in the ophthalmic ultrasound industry, recognized for quality products and global distribution. Competitors offering similar products at lower prices and the development of optical technologies for ophthalmic biometrics and imaging represent potential challenges to the Company's market position.
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Allurion Technologies Inc is a medical device company that specializes in developing non-surgical solutions for weight loss. Their business model is centered around providing a comprehensive weight loss program that combines their innovative medical device, the Elipse Balloon, with personalized coaching and support. They target individuals seeking a non-invasive and convenient approach to achieving their weight loss goals.
Alcon Inc's business model revolves around providing advanced eye care products and services, including pharmaceuticals, surgical equipment, and vision care solutions.
Abbott Laboratories operates as a diversified healthcare company with a focus on developing and manufacturing a wide range of health-related products, including pharmaceuticals, medical devices, nutritional products, and diagnostic technologies. Their business model emphasizes innovation and quality, aiming to address the diverse needs of patients and healthcare providers across various sectors globally. By leveraging their expertise and extensive portfolio, Abbott strives to enhance patient outcomes and improve the overall quality of life.
Zynex Inc's business model revolves around the development and distribution of medical devices and software that provide non-invasive electrotherapy for pain management and rehabilitation.
Sources:
Escalon Medical Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Escalon Medical Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
